FDA allows Houston cancer doctor to resume drug trial

Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw

Here's who could be helped by new cancer drug — and when

Cancers, Free Full-Text

Novartis challenges Pfizer with strong breast cancer drug data

Here's who could be helped by new cancer drug — and when

FibroGen limited access to Duchenne muscular dystrophy drug after failed clinical trial. But mom says it works for her son. - San Francisco Business Times

UTHealth Houston

Vaccines, Free Full-Text

Houston doctor discovers way to treat pancreatic cancer during clinical trial

Shubham Pant MD Anderson Cancer Center

FDA panel: Benefit of 'highly anticipated' lung cancer drug can't be interpreted reliably